Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BharatGen
Hyderabad, Telangana, Indiabharatgen.tech ↗
- Ownership
- Private
- Employees
- ~700
- Development stage
- Other
01
Overview
Bharat Biotech has delivered over nine billion doses globally as of May 2025 across a portfolio exceeding nineteen commercialized vaccines and four biotherapeutics. Its Hillchol oral cholera vaccine completed successful Phase III trials demonstrating efficacy against both Ogawa and Inaba serotypes. The company was a key global supplier during the COVID‑19 pandemic with Covaxin approved in several countries. It recently entered the advanced therapeutics space with investments into CAR-T/CAR-NK/off-the-shelf gene therapy manufacturing capabilities at its Hyderabad Genome Valley site.[4][5]
- Therapeutic areas
- EndocrinologyInfectious Diseases
- Modalities
- VaccineCell therapy (including CAR-T cell therapy)Gene therapy (including off-the-shelf gene therapies)Recombinant proteinSmall molecule (for select biotherapeutics)Monoclonal antibody (potentially in pipeline per advanced therapeutics focus)
- Industry
- Biotech
02
Partnerships
WyethAcambisNovavaxOcugen (COVID‑19 US partnership)University of Wisconsin-Madison (collaboration on advanced therapeutics)Bill & Melinda Gates Foundation (funding/support)PATH (Global Health org.)National Institutes of Health (USA)CDC (USA)Stanford University School of Medicine
Beyond the preview
Go deeper on BharatGen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BharatGen.